Systemic and renal oxidative stress in the pathogenesis of hypertension: Modulation of long-term control of arterial blood pressure by resveratrol

Frontiers in Physiology

Volumn 5 AUG, Issue , 2014, Pages

  Hamza, Shereen M ^a   Dyck, Jason R B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Hypertension; Oxidative stress; Pressure natriuresis; Renal dysfunction; Resveratrol

Indexed keywords

CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; ENDOTHELIN 1; HEME OXYGENASE 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SIRTUIN 1; SUPEROXIDE DISMUTASE;

ACUTE KIDNEY FAILURE; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CALORIC RESTRICTION; CHRONIC KIDNEY DISEASE; DIURESIS; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG METABOLISM; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY DENERVATION; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; KIDNEY VASCULAR RESISTANCE; NATRIURESIS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PLASMA HALF LIFE; RED WINE; RENAL PROTECTION; SINGLE DRUG DOSE; SODIUM EXCRETION; SYMPATHETIC TONE; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

EID: 84906516686     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00292     Document Type: Article

References (242)

1. Adams, V., Linke, A., Krankel, N., Erbs, S., Gielen, S., Mobius-Winkler, S., et al. (2005). Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 111, 555-562. doi:10.1161/01.CIR.0000154560.88933.7E
2. Adlam, D., Bendall, J. K., De Bono, J. P., Alp, N. J., Khoo, J., Nicoli, T., et al. (2007). Relationships between nitric oxide-mediated endothelial function, eNOS coupling and blood pressure revealed by eNOS-GTP cyclohydrolase 1 double transgenic mice. Exp. Physiol . 92, 119-126. doi:10.1113/expphysiol.2006.035113
3. Agarwal, D., Welsch, M. A., Keller, J. N., and Francis, J. (2011). Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR. Basic Res. Cardiol . 106, 1069-1085. doi:10.1007/s00395-011-0231-7
4. Albani, D., Polito, L., and Forloni, G. (2010). Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. J. Alzheimers. Dis . 19, 11-26. doi:10.3233/JAD-2010-1215
5. Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., et al. (2007). Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res . 100, 1512-1521. doi:10.1161/01.RES.0000267723.65696.4a
6. Al Ghouleh, I., Khoo, N. K., Knaus, U. G., Griendling, K. K., Touyz, R. M., Thannickal, V. J., et al. (2011). Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic. Biol. Med . 51, 1271-1288. doi:10.1016/j.freeradbiomed.2011.06.011
7. Anwar, M. A., Shalhoub, J., Lim, C. S., Gohel, M. S., and Davies, A. H. (2012). The effect of pressure-induced mechanical stretch on vascular wall differential gene expression. J. Vasc. Res . 49, 463-478. doi:10.1159/000339151
8. Aubin, M. C., Lajoie, C., Clement, R., Gosselin, H., Calderone, A., and Perrault, L. P. (2008). Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J. Pharmacol. Exp. Ther . 325, 961-968. doi:10.1124/jpet.107.135061
9. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342. doi:10.1038/nature05354
10. Baur, J. A., and Sinclair, D. A. (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov . 5, 493-506. doi:10.1038/nrd2060
11. Belmonte, S. L., and Blaxall, B. C. (2011). G protein coupled receptor kinases as therapeutic targets in cardiovascular disease. Circ. Res . 109, 309-319. doi:10.1161/CIRCRESAHA.110.231233
12. Bernatova, I., Pechanova, O., Babal, P., Kysela, S., Stvrtina, S., and Andriantsitohaina, R. (2002). Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am. J. Physiol. Heart Circ. Physiol . 282, H942-H948. doi:10.1152/ajpheart.00724.2001
13. Bertelli, A. A., Migliori, M., Panichi, V., Origlia, N., Filippi, C., Das, D. K., et al. (2002). Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann. N.Y. Acad. Sci . 957, 230-238. doi:10.1111/j.1749-6632.2002.tb02919.x
14. Bhatia, K., Elmarakby, A. A., El-Remessy, A. B., and Sullivan, J. C. (2012). Oxidative stress contributes to sex differences in angiotensin II-mediated hypertension in spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol . 302, R274-R282. doi:10.1152/ajpregu.00546.2011
15. Bhatt, S. R., Lokhandwala, M. F., and Banday, A. A. (2011). Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur. J. Pharmacol . 667, 258-264. doi:10.1016/j.ejphar.2011.05.026
16. Bianchi, G., Cusi, D., Ferrari, P., Barlassina, C., Pati, P., Salardi, S., et al. (1988). Renal abnormalities at the prehypertensive stage of essential hypertension. J. Cardiovasc. Pharmacol . 12(Suppl 3), s43-s48. doi:10.1097/00005344-198800120-00007
17. Bianchi, G., Fox, U., DiFrancesco, G. F., Bardi, U., and Radice, M. (1973). The hypertensive role of the kidney in spontaneously hypertensive rats. Clin. Sci. Mol. Med . 45(Suppl), 135s-139s.
18. Bianchi, G., Fox, U., DiFrancesco, G. F., Giovanetti, P. M., and Pagetti, D. (1978). Blood pressure changes produced by kidney cross-transplantation between spontaneuously hypertensive and normotensive rats. Clin. Sci. Mol. Med . 47, 435-448.
19. Bisognano, J. D., Bakris, G., Nadim, M. K., Sanchez, L., Kroon, A. A., Schafer, J., et al. (2011). Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J. Am. Coll. Cardiol . 58, 765-773. doi:10.1016/j.jacc.2011.06.008
20. Bo, S., Ciccone, G., Castiglione, A., Gambino, R., De Michieli, F., Villois, P., et al. (2013). Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr. Med. Chem . 20, 1323-1331. doi:10.2174/0929867311320100009
21. Boocock, D. J., Faust, G. E., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., et al. (2007). Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers Prev . 16, 1246-1252. doi:10.1158/1055-9965.EPI-07-0022
22. Braga, V. A. (2010). Dietary salt enhances angiotensin-II-induced superoxide formation in the rostral ventrolateral medulla. Auton. Neurosci . 155, 14-18. doi:10.1016/j.autneu.2009.12.007
23. Brasnyo, P., Molnar, G. A., Mohas, M., Marko, L., Laczy, B., Cseh, J., et al. (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr . 106, 383-389. doi:10.1017/S0007114511000316
24. Buchwalow, I. B., Cacanyiova, S., Neumann, J., Samoilova, V. E., Boecker, W., and Kristek, F. (2008). The role of arterial smooth muscle in vasorelaxation. Biochem. Biophys. Res. Commun . 377, 504-507. doi:10.1016/j.bbrc.2008.10.019
25. Buchwalow, I. B., Podzuweit, T., Samoilova, V. E., Wellner, M., Haller, H., Grote, S., et al. (2004). An in situ evidence for autocrine function of NO in the vasculature. Nitric Oxide 10, 203-212. doi:10.1016/j.niox.2004.04.004
26. Buluc, M., and Demirel-Yilmaz, E. (2006). Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endothelium. Vascul. Pharmacol . 44, 231-237. doi:10.1016/j.vph.2005.12.003
27. Calderone, V., Martelli, A., Testai, L., Martinotti, E., and Breschi, M. C. (2007). Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels. Naunyn Schmiedebergs Arch. Pharmacol . 375, 73-80. doi:10.1007/s00210-006-0129-3
28. Calhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., et al. (2008). Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51, 1403-1419. doi:10.1161/HYPERTENSIONAHA.108.189141
29. Campese, V. M., and Kogosov, E. (1995). Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 25(4 Pt 2), 878-882. doi:10.1161/01.HYP.25.4.878
30. Campos-Toimil, M., Elies, J., Alvarez, E., Verde, I., and Orallo, F. (2007). Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes. Eur. J. Pharmacol . 577, 91-99. doi:10.1016/j.ejphar.2007.08.003
31. Caner, M., Karter, Y., Uzun, H., Curgunlu, A., Vehid, S., Balci, H., et al. (2006). Oxidative stress in human in sustained and white coat hypertension. Int. J. Clin. Pract . 60, 1565-1571. doi:10.1111/j.1742-1241.2006.00959.x
32. Cao, X., Luo, T., Luo, X., and Tang, Z. (2014). Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice. Hypertens. Res . doi:10.1038/hr.2014.90. [Epub ahead of print].
33. Castilla, P., Davalos, A., Teruel, J. L., Cerrato, F., Fernandez-Lucas, M., Merino, J. L., et al. (2008). Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients. Am. J. Clin. Nutr . 87, 1053-1061.
34. Castilla, P., Echarri, R., Davalos, A., Cerrato, F., Ortega, H., Teruel, J. L., et al. (2006). Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am. J. Clin. Nutr . 84, 252-262.
35. Catalgol, B., Batirel, S., Taga, Y., and Ozer, N. K. (2012). Resveratrol:french paradox revisited. Front. Pharmacol . 3:141. doi:10.3389/fphar.2012.00141
36. Chabrashvili, T., Kitiyakara, C., Blau, J., Karber, A., Aslam, S., Welch, W. J., et al. (2003). Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am. J. Physiol. Regul. Integr. Comp. Physiol . 285, R117-R124. doi:10.1152/ajpregu.00476.2002
37. Chabrashvili, T., Tojo, A., Onozato, M. L., Kitiyakara, C., Quinn, M. T., Fujita, T., et al. (2002). Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39, 269-274. doi:10.1161/hy0202.103264
38. Chan, S. H., Hsu, K. S., Huang, C. C., Wang, L. L., Ou, C. C., and Chan, J. Y. (2005). NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ. Res . 97, 772-780. doi:10.1161/01.RES.0000185804.79157.C0
39. Chan, V., Fenning, A., Iyer, A., Hoey, A., and Brown, L. (2011). Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Curr. Pharm. Biotechnol . 12, 429-436. doi:10.2174/138920111794480552
40. Chander, V., and Chopra, K. (2006). Possible role of nitric oxide in the protective effect of resveratrol in 5/6th nephrectomized rats. J. Surg. Res . 133, 129-135. doi:10.1016/j.jss.2005.10.010
41. Charpie, J. R., and Webb, R. C. (1993). Vascular myocyte-derived nitric oxide is an autocrine that limits vasoconstriction. Biochem. Biophys. Res. Commun . 194, 763-768.
42. Cheah, L. S., Gwee, M., Das, R., Ballard, H., Yang, Y. F., Daniel, E. E., et al. (2002). Evidence for the existence of a constitutive nitric oxide synthase in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol . 29, 725-727. doi:10.1046/j.1440-1681.2002.03707.x
43. Chen, F., Haigh, S., Barman, S., and Fulton, D. J. (2012). From form to function: the role of Nox4 in the cardiovascular system. Front. Physiol . 3:412. doi:10.3389/fphys.2012.00412
44. Chen, S., Ge, Y., Si, J., Rifai, A., Dworkin, L. D., and Gong, R. (2008). Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade. Kidney Int . 74, 1128-1138. doi:10.1038/ki.2008.380
45. Chen, X., Touyz, R. M., Park, J. B., and Schiffrin, E. L. (2001). Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38(3 Pt 2), 606-611. doi:10.1161/hy09t1.094005
46. Chobanian, A. V. (2011). Mixed messages on blood pressure goals. Hypertension 57, 1039-1040. doi:10.1161/HYPERTENSIONAHA.111.170514
47. Chung, J. H., Manganiello, V., and Dyck, J. R. (2012). Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol . 22, 546-554. doi:10.1016/j.tcb.2012.07.004
48. Converse, R. L. Jr., Jacobsen, T. N., Toto, R. D., Jost, C. M., Cosentino, F., Fouad-Tarazi, F., et al. (1992). Sympathetic overactivity in patients with chronic renal failure. N. Engl. J. Med . 327, 1912-1918. doi:10.1056/NEJM199212313272704
49. Cottone, S., Mule, G., Guarneri, M., Palermo, A., Lorito, M. C., Riccobene, R., et al. (2009). Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients. Nephrol. Dial. Transplant 24, 497-503. doi:10.1093/ndt/gfn489
50. Cowley, A. W. Jr. (1992). Long-term control of arterial blood pressure. Physiol. Rev . 72, 231-300.
51. Cowley, A. W. Jr. (2008). Renal medullary oxidative stress, pressure-natriuresis, and hypertension. Hypertension 52, 777-786. doi:10.1161/HYPERTENSIONAHA.107.092858
52. Cowley, A. W. Jr., Mori, T., Mattson, D., and Zou, A. P. (2003). Role of renal NO production in the regulation of medullary blood flow. Am. J. Physiol. Regul. Integr. Comp. Physiol . 284, R1355-R1369. doi:10.1152/ajpregu.00701.2002
53. Cowley, A. W. Jr., and Roman, R. J. (1996). The role of the kidney in hypertension. JAMA 275, 1581-1589. doi:10.1001/jama.1996.03530440061038
54. Cuevas, S., Villar, V. A., Jose, P. A., and Armando, I. (2013). Renal dopamine receptors, oxidative stress, and hypertension. Int. J. Mol. Sci . 14, 17553-17572. doi:10.3390/ijms140917553
55. Curtis, J. J., Luke, R. G., Dustan, H. P., Kashgarian, M., Whelchel, J. D., Jones, P., et al. (1983). Remission of essential hypertension after renal transplantation. N. Engl. J. Med . 309, 1009-1015. doi:10.1056/NEJM198310273091702
56. Dahl, L. K., and Heine, M. (1975). Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ. Res . 36, 692-696. doi:10.1161/01.RES.36.6.692
57. Dahl, L. K., Heine, M., and Thompson, K. (1974). Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ. Res . 40, 94-101.
58. Das, S., Khan, N., Mukherjee, S., Bagchi, D., Gurusamy, N., Swartz, H., et al. (2008). Redox regulation of resveratrol-mediated switching of death signal into survival signal. Free Radic. Biol. Med . 44, 82-90. doi:10.1016/j.freeradbiomed.2007.09.008
59. DiBona, G. F., and Kopp, U. C. (1997). Neural control of renal function. Physiol. Rev . 77, 75-197.
60. Diebolt, M., Bucher, B., and Andriantsitohaina, R. (2001). Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 38, 159-165. doi:10.1161/01.HYP.38.2.159
61. Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., et al. (2010). Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res . 107, 106-116. doi:10.1161/CIRCRESAHA.109.214601
62. Dillenburg, D. R., Mostarda, C., Moraes-Silva, I. C., Ferreira, D., Bos Dda, S., Duarte, A. A., et al. (2013). Resveratrol and grape juice differentially ameliorate cardiovascular autonomic modulation in L-NAME-treated rats. Auton. Neurosci . 179, 9-13. doi:10.1016/j.autneu.2013.06.002
63. Dolinsky, V. W., Chakrabarti, S., Pereira, T. J., Oka, T., Levasseur, J., Beker, D., et al. (2013). Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. Biochim. Biophys. Acta 1832, 1723-1733. doi:10.1016/j.bbadis.2013.05.018
64. Dolinsky, V. W., Chan, A. Y., Robillard Frayne, I., Light, P. E., Des Rosiers, C., and Dyck, J. R. (2009). Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation 119, 1643-1652. doi:10.1161/CIRCULATIONAHA.108.787440
65. Dolinsky, V. W., Morton, J. S., Oka, T., Robillard-Frayne, I., Bagdan, M., Lopaschuk, G. D., et al. (2010). Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat. Hypertension 56, 412-421. doi:10.1161/HYPERTENSIONAHA.110.154732
66. Dong, W., Gao, D., Lin, H., Zhang, X., Li, N., and Li, F. (2008). New insights into mechanism for the effect of resveratrol preconditioning against cerebral ischemic stroke: possible role of matrix metalloprotease-9. Med. Hypotheses 70, 52-55. doi:10.1016/j.mehy.2007.04.033
67. Doughan, A. K., Harrison, D. G., and Dikalov, S. I. (2008). Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res . 102, 488-496. doi:10.1161/CIRCRESAHA.107.162800
68. Droge, W. (2002). Free radicals in the physiological control of cell function. Physiol. Rev . 82, 47-95. doi:10.1152/physrev.00018.2001
69. Dudley, J., Das, S., Mukherjee, S., and Das, D. K. (2009). Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J. Nutr. Biochem . 20, 443-452. doi:10.1016/j.jnutbio.2008.05.003
70. El-Mowafy, A. M., Alkhalaf, M., and El-Kashef, H. A. (2008). Resveratrol reverses hydrogen peroxide-induced proliferative effects in human coronary smooth muscle cells: a novel signaling mechanism. Arch. Med. Res . 39, 155-161. doi:10.1016/j.arcmed.2007.09.010
71. Forman, H. J., Fukuto, J. M., Miller, T., Zhang, H., Rinna, A., and Levy, S. (2008). The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch. Biochem. Biophys . 477, 183-195. doi:10.1016/j.abb.2008.06.011
72. Forstermann, U. (2008). Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Clin. Pract. Cardiovasc. Med . 5, 338-349. doi:10.1038/ncpcardio1211
73. Franco, M. C., Kawamoto, E. M., Gorjao, R., Rastelli, V. M., Curi, R., Scavone, C., et al. (2007). Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: evidence of lipid peroxidation. Pediatr. Res . 62, 204-208. doi:10.1203/PDR.0b013e3180986d04
74. Fujita, M., Ando, K., Kawarazaki, H., Kawarasaki, C., Muraoka, K., Ohtsu, H., et al. (2012). Sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in salt-induced chronic kidney disease. Hypertension 59, 105-112. doi:10.1161/HYPERTENSIONAHA.111.182923
75. Fujita, M., Ando, K., Nagae, A., and Fujita, T. (2007). Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 50, 360-367. doi:10.1161/HYPERTENSIONAHA.107.091009
76. Fujita, M., and Fujita, T. (2013). The role of CNS in salt-sensitive hypertension. Curr. Hypertens. Rep . 15, 390-394. doi:10.1007/s11906-013-0358-z
77. Fujita, T., Henry, W. L., Bartter, F. C., Lake, C. R., and Delea, C. S. (1980). Factors influencing blood pressure in salt-sensitive patients with hypertension. Am. J. Med . 69, 334-344. doi:10.1016/0002-9343(80)90002-9
78. Ghanim, H., Sia, C. L., Abuaysheh, S., Korzeniewski, K., Patnaik, P., Marumganti, A., et al. (2010). An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J. Clin. Endocrinol. Metab . 95, E1-E8. doi:10.1210/jc.2010-0482
79. Ghanim, H., Sia, C. L., Korzeniewski, K., Lohano, T., Abuaysheh, S., Marumganti, A., et al. (2011). A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J. Clin. Endocrinol. Metab . 96, 1409-1414. doi:10.1210/jc.2010-1812
80. Gojkovic-Bukarica, L., Kanjuh, V., Novakovic, R., Protic, D., Cvejic, J., and Atanackovic, M. (2012). The differential effect of resveratrol on the renal artery of normal and diabetic rats. BMC Pharmacol. Toxicol . 13(Suppl 1):A48.
81. Gojkovic-Bukarica, L., Novakovic, A., Kanjuh, V., Bumbasirevic, M., Lesic, A., and Heinle, H. (2008). A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol. J. Pharmacol. Sci . 108, 124-130. doi:10.1254/jphs.08128FP
82. Gongora, M. C., Qin, Z., Laude, K., Kim, H. W., McCann, L., Folz, J. R., et al. (2006). Role of extracellular superoxide dismutase in hypertension. Hypertension 48, 473-481. doi:10.1161/01.HYP.0000235682.47673.ab
83. Gordish, K. L., and Beierwaltes, W. H. (2014). Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging. Am. J. Physiol. Renal Physiol . 306, F542-F550. doi:10.1152/ajprenal.00437.2013
84. Goyal, M. M., and Basak, A. (2010). Human catalase: looking for complete identity. Protein Cell 1, 888-897. doi:10.1007/s13238-010-0113-z
85. Grande, M. T., Pascual, G., Riolobos, A. S., Clemente-Lorenzo, M., Bardaji, B., Barreiro, L., et al. (2011). Increased oxidative stress, the renin-angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice. Free Radic. Biol. Med . 51, 1831-1841. doi:10.1016/j.freeradbiomed.2011.08.014
86. Guarente, L. (2013). Calorie restriction and sirtuins revisited. Genes Dev . 27, 2072-2085. doi:10.1101/gad.227439.113
87. Guo, R., Li, W., Liu, B., Li, S., Zhang, B., and Xu, Y. (2014). Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro . Med. Sci. Monit. Basic Res . 20, 82-92. doi:10.12659/MSMBR.890858
88. Guyton, A. C. (1980). Arterial Pressure and Hypertension . Philadelphia, PA: WB Saunders Co.
89. Guyton, A. C. (1990a). Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am. J. Physiol . 259(5 Pt 2), R865-R877.
90. Guyton, A. C. (1990b). The surprising kidney-fluid mechanism for pressure control-its infinite gain! Hypertension 16, 725-730.
91. Guyton, A. C., Coleman, T. G., Fourcade, J. C., and Navar, L. G. (1969). Physiologic control of arterial pressure. Bull. N.Y. Acad. Med . 45, 811-830.
92. Guyton, A. C., Cowley, A. W. Jr., Young, D. B., Coleman, T. G., Hall, J. E., and DeClue,. J. W. (1976). "Integration and control of circulatory function," in International Review of Physiology: Cardiovascular Physiology II , eds A. C. Guyton, and A.W. Cowley, Jr (Baltimore, MD: University Park Press).
93. Haga, J. H., Li, Y. S., and Chien, S. (2007). Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J. Biomech . 40, 947-960. doi:10.1016/j.jbiomech.2006.04.011
94. Hall, J. E. (1994). Louis, K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 23, 381-394. doi:10.1161/01.HYP.23.3.381
95. Hall, J. E., Granger, J. P., Hester, R. L., and Montani, J. P. (1986a). Mechanisms of sodium balance in hypertension: role of pressure natriuresis. J. Hypertens. Suppl . 4, S57-S65.
96. Hall, J. E., Montani, J. P., Woods, L. L., and Mizelle, H. L. (1986b). Renal escape from vasopressin: role of pressure diuresis. Am. J. Physiol . 250(5 Pt 2), F907-F916.
97. Haque, M. Z., and Majid, D. S. (2011). High salt intake delayed angiotensin II-induced hypertension in mice with a genetic variant of NADPH oxidase. Am. J. Hypertens . 24, 114-118. doi:10.1038/ajh.2010.173
98. Harikumar, K. B., and Aggarwal, B. B. (2008). Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 1020-1035. doi:10.4161/cc.7.8.5740
99. Hashimoto, M., Kim, S., Eto, M., Iijima, K., Ako, J., Yoshizumi, M., et al. (2001). Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am. J. Cardiol . 88, 1457-1460, A9. doi:10.1016/S0002-9149(01)02137-3
100. Hollenberg, S. M. (2010). Think locally: evaluation of the microcirculation in sepsis. Intensive Care Med . 36, 1807-1809. doi:10.1007/s00134-010-1973-7
101. Holloszy, J. O., and Fontana, L. (2007). Caloric restriction in humans. Exp. Gerontol . 42, 709-712. doi:10.1016/j.exger.2007.03.009
102. Holthoff, J. H., Wang, Z., Seely, K. A., Gokden, N., and Mayeux, P. R. (2012). Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int . 81, 370-378. doi:10.1038/ki.2011.347
103. Holthoff, J. H., Woodling, K. A., Doerge, D. R., Burns, S. T., Hinson, J. A., and Mayeux, P. R. (2010). Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite. Biochem. Pharmacol . 80, 1260-1265. doi:10.1016/j.bcp.2010.06.027
104. Jacob, C., Jamier, V., and Ba, L. A. (2011). Redox active secondary metabolites. Curr. Opin. Chem. Biol . 15, 149-155. doi:10.1016/j.cbpa.2010.10.015
105. Jia, Z., Aoyagi, T., and Yang, T. (2010). mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Hypertension 55, 539-546. doi:10.1161/HYPERTENSIONAHA.109.144840
106. Jimenez, R., Lopez-Sepulveda, R., Kadmiri, M., Romero, M., Vera, R., Sanchez, M., et al. (2007). Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase. Free Radic. Biol. Med . 43, 462-473. doi:10.1016/j.freeradbiomed.2007.05.007
107. Juncos, R., Hong, N. J., and Garvin, J. L. (2006). Differential effects of superoxide on luminal and basolateral Na+/H+ exchange in the thick ascending limb. Am. J. Physiol. Regul. Integr. Comp. Physiol . 290, R79-R83. doi:10.1152/ajpregu.00447.2005
108. Just, A., Whitten, C. L., and Arendshorst, W. J. (2008). Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors. Am. J. Physiol. Renal Physiol . 294, F719-F728. doi:10.1152/ajprenal.00506.2007
109. Kannel, W. B. (2000). Fifty years of Framingham Study contributions to understanding hypertension. J. Hum. Hypertens . 14, 83-90. doi:10.1038/sj.jhh.1000949
110. Kawabe, K., Watanabe, T. X., Shiono, K., and Sokabe, H. (1978). Influence on blood pressure of renal isografts between spontaneously hypertensive and normotensive rats, utilizing the F1 hybrids. Jpn. Heart J . 19, 886-894. doi:10.1536/ihj.19.886
111. Kishi, T., Hirooka, Y., Kimura, Y., Ito, K., Shimokawa, H., and Takeshita, A. (2004). Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109, 2357-2362. doi:10.1161/01.CIR.0000128695.49900.12
112. Kishi, T., Hirooka, Y., Kimura, Y., Sakai, K., Ito, K., Shimokawa, H., et al. (2003). Overexpression of eNOS in RVLM improves impaired baroreflex control of heart rate in SHRSP. Rostral ventrolateral medulla. Stroke-prone spontaneously hypertensive rats. Hypertension 41, 255-260. doi:10.1161/01.HYP.0000050649.30821.CB
113. Kitada, M., and Koya, D. (2013). Renal protective effects of resveratrol. Oxid. Med. Cell. Longev . 2013:568093. doi:10.1155/2013/568093
114. Kitada, M., Kume, S., Takeda-Watanabe, A., Kanasaki, K., and Koya, D. (2013). Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin. Sci . 124, 153-164. doi:10.1042/CS20120190
115. Kitiyakara, C., Chabrashvili, T., Chen, Y., Blau, J., Karber, A., Aslam, S., et al. (2003). Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J. Am. Soc. Nephrol . 14, 2775-2782. doi:10.1097/01.ASN.0000092145.90389.65
116. Kizhakekuttu, T. J., and Widlansky, M. E. (2010). Natural antioxidants and hypertension: promise and challenges. Cardiovasc. Ther . 28, e20-e32. doi:10.1111/j.1755-5922.2010.00137.x
117. Klinge, C. M., Blankenship, K. A., Risinger, K. E., Bhatnagar, S., Noisin, E. L., Sumanasekera, W. K., et al. (2005). Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J. Biol. Chem . 280, 7460-7468. doi:10.1074/jbc.M411565200
118. Koga, Y., Hirooka, Y., Araki, S., Nozoe, M., Kishi, T., and Sunagawa, K. (2008). High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertens. Res . 31, 2075-2083. doi:10.1291/hypres.31.2075
119. Kopp, U. C. (2011). Endothelin in the control of renal sympathetic nerve activity. Contrib. Nephrol . 172, 107-119. doi:10.1159/000328688
120. Kroon, P. A., Iyer, A., Chunduri, P., Chan, V., and Brown, L. (2010). The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. Curr. Med. Chem . 17, 2442-2455. doi:10.2174/092986710791556032
121. Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., et al. (2009). Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275-1281. doi:10.1016/S0140-6736(09)60566-3
122. Lacy, F., Kailasam, M. T., O'Connor, D. T., Schmid-Schonbein, G. W., and Parmer, R. J. (2000). Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36, 878-884. doi:10.1161/01.HYP.36.5.878
123. Lacy, F., O'Connor, D. T., and Schmid-Schonbein, G. W. (1998). Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J. Hypertens . 16, 291-303. doi:10.1097/00004872-199816030-00006
124. Lai, E. Y., Wellstein, A., Welch, W. J., and Wilcox, C. S. (2011). Superoxide modulates myogenic contractions of mouse afferent arterioles. Hypertension 58, 650-656. doi:10.1161/HYPERTENSIONAHA.111.170472
125. Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., et al. (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest . 111, 1201-1209. doi:10.1172/JCI200314172
126. Lassegue, B., San Martin, A., and Griendling, K. K. (2012). Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res . 110, 1364-1390. doi:10.1161/CIRCRESAHA.111.243972
127. Laursen, J. B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B. A., and Harrison, D. G. (1997). Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95, 588-593. doi:10.1161/01.CIR.95.3.588
128. Lawes, C. M., Vander Hoorn, S., and Rodgers, A. (2008). Global burden of blood-pressure-related disease, 2001. Lancet 371, 1513-1518. doi:10.1016/S0140-6736(08)60655-8
129. Lee, M. Y., and Griendling, K. K. (2008). Redox signaling, vascular function, and hypertension. Antioxid. Redox Signal . 10, 1045-1059. doi:10.1089/ars.2007.1986
130. Liang, J., Tian, S., Han, J., and Xiong, P. (2014). Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction. Ren. Fail . 36, 285-291. doi:10.3109/0886022X.2013.844644
131. Lin, J. P., Vitek, L., and Schwertner, H. A. (2010). Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin. Chem . 56, 1535-1543. doi:10.1373/clinchem.2010.151043
132. Liu, B. L., Zhang, X., Zhang, W., and Zhen, H. N. (2007). New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol. Ther . 6, 1833-1836. doi:10.4161/cbt.6.12.5161
133. Liu, Z., Song, Y., Zhang, X., Zhang, W., Mao, W., Wang, W., et al. (2005). Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin. Exp. Pharmacol. Physiol . 32, 1049-1054. doi:10.1111/j.1440-1681.2005.04299.x
134. Lo, J., Patel, V. B., Wang, Z., Levasseur, J., Kaufman, S., Penninger, J. M., et al. (2013). Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats. Exp. Physiol . 98, 109-122. doi:10.1113/expphysiol.2012.067165
135. Lob, H. E., Vinh, A., Li, L., Blinder, Y., Offermanns, S., and Harrison, D. G. (2011). Role of vascular extracellular superoxide dismutase in hypertension. Hypertension 58, 232-239. doi:10.1161/HYPERTENSIONAHA.111.172718
136. Lopes, H. F., Martin, K. L., Nashar, K., Morrow, J. D., Goodfriend, T. L., and Egan, B. M. (2003). DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 41, 422-430. doi:10.1161/01.HYP.0000053450.19998.11
137. Lundy, D. J., and Trzeciak, S. (2009). Microcirculatory dysfunction in sepsis. Crit. Care Clin . 25, 721-731, viii. doi:10.1016/j.ccc.2009.06.002
138. Ma, H. J., Cao, Y. K., Liu, Y. X., Wang, R., and Wu, Y. M. (2008). Microinjection of resveratrol into rostral ventrolateral medulla decreases sympathetic vasomotor tone through nitric oxide and intracellular Ca2+ in anesthetized male rats. Acta Pharmacol. Sin . 29, 906-912. doi:10.1111/j.1745-7254.2008.00827.x
139. Makino, A., Skelton, M. M., Zou, A. P., Roman, R. J., and Cowley, A. W. Jr. (2002). Increased renal medullary oxidative stress produces hypertension. Hypertension 39(2 Pt 2), 667-672. doi:10.1161/hy0202.103469
140. Matsuo, S., Nakamura, Y., Takahashi, M., Ouchi, Y., Hosoda, K., Nozawa, M., et al. (2001). Effect of red wine and ethanol on production of nitric oxide in healthy subjects. Am. J. Cardiol . 87, 1029-1031: A6. doi:10.1016/S0002-9149(01)01446-1
141. Mattagajasingh, I., Kim, C. S., Naqvi, A., Yamamori, T., Hoffman, T. A., Jung, S. B., et al. (2007). SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A . 104, 14855-14860. doi:10.1073/pnas.0704329104
142. Maulik, N. (2006). Reactive oxygen species drives myocardial angiogenesis? Antioxid. Redox Signal . 8, 2161-2168. doi:10.1089/ars.2006.8.2161
143. Maulik, N., and Das, D. K. (2008). Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim. Biophys. Acta 1780, 1368-1382. doi:10.1016/j.bbagen.2007.12.008
144. Miatello, R., Vazquez, M., Renna, N., Cruzado, M., Zumino, A. P., and Risler, N. (2005). Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am. J. Hypertens . 18, 864-870. doi:10.1016/j.amjhyper.2004.12.012
145. Milanovic, J. G., Mihailovic-Stanojevic, N., Miloradovic, Z., Jacevic, V., Milosavljevic, I., Milanovic, S., et al. (2010). Resveratrol reduced blood pressure, changes of antioxidant enzyme activity and histological parameters in experimental model of malignant hypertension. J. Hypertens . 28(eSupplement A):e500.
146. Miyata, N., and Cowley, A. W. Jr. (1999). Renal intramedullary infusion of L-arginine prevents reduction of medullary blood flow and hypertension in Dahl salt-sensitive rats. Hypertension 33(1 Pt 2), 446-450. doi:10.1161/01.HYP.33.1.446
147. Miyazaki, R., Ichiki, T., Hashimoto, T., Inanaga, K., Imayama, I., Sadoshima, J., et al. (2008). SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol . 28, 1263-1269. doi:10.1161/ATVBAHA.108.166991
148. Mizutani, K., Ikeda, K., Kawai, Y., and Yamori, Y. (1999). Extract of wine phenolics improves aortic biomechanical properties in stroke-prone spontaneously hypertensive rats (SHRSP). J. Nutr. Sci. Vitaminol . 45, 95-106.
149. Mizutani, K., Ikeda, K., Kawai, Y., and Yamori, Y. (2001). Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol . 28, 55-59. doi:10.1046/j.1440-1681.2001.03415.x
150. Mokni, M., Elkahoui, S., Limam, F., Amri, M., and Aouani, E. (2007). Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem. Res . 32, 981-987. doi:10.1007/s11064-006-9255-z
151. Montezano, A. C., and Touyz, R. M. (2012). Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: a basic science update for the clinician. Can. J. Cardiol . 28, 288-295. doi:10.1016/j.cjca.2012.01.017
152. Muirhead, E. E. (1993). Renal vasodepressor mechanisms: the medullipin system. J. Hypertens. Suppl . 11, S53-S58.
153. Muller, D. N., Kvakan, H., and Luft, F. C. (2011). Immune-related effects in hypertension and target-organ damage. Curr. Opin. Nephrol. Hypertens . 20, 113-117. doi:10.1097/MNH.0b013e3283436f88
154. Nagae, A., Fujita, M., Kawarazaki, H., Matsui, H., Ando, K., and Fujita, T. (2009). Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation 119, 978-986. doi:10.1161/CIRCULATIONAHA.108.824730
155. Nakanishi, K., Mattson, D. L., and Cowley, A. W. Jr. (1995). Role of renal medullary blood flow in the development of L-NAME hypertension in rats. Am. J. Physiol . 268(2 Pt 2), R317-R323.
156. Nakazono, K., Watanabe, N., Matsuno, K., Sasaki, J., Sato, T., and Inoue, M. (1991). Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. U.S.A . 88, 10045-10048.
157. Nicholson, S. K., Tucker, G. A., and Brameld, J. M. (2008). Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc. Nutr. Soc . 67, 42-47. doi:10.1017/S0029665108006009
158. Nishino, T., Okamoto, K., Eger, B. T., and Pai, E. F. (2008). Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J . 275, 3278-3289. doi:10.1111/j.1742-4658.2008.06489.x
159. Oliveira-Sales, E. B., Colombari, D. S., Davisson, R. L., Kasparov, S., Hirata, A. E., Campos, R. R., et al. (2010). Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 56, 290-296. doi:10.1161/HYPERTENSIONAHA.110.150425
160. Ortiz, A. (2000). Nephrology forum: apoptotic regulatory proteins in renal injury. Kidney Int . 58, 467-485. doi:10.1046/j.1523-1755.2000.00188.x
161. Ortiz, P. A., and Garvin, J. L. (2002). Interaction of O(2)(-) and NO in the thick ascending limb. Hypertension 39(2 Pt 2), 591-596. doi:10.1161/hy0202.103287
162. Osborn, J. W., Averina, V. A., and Fink, G. D. (2009). Current computational models do not reveal the importance of the nervous system in long-term control of arterial pressure. Exp. Physiol . 94, 389-396. doi:10.1113/expphysiol.2008.043281
163. Palm, F, and Nordquist, L. (2011). Renal oxidative stress, oxygenation and hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol . 301, R1229-R1241. doi:10.1152/ajpregu.00720.2010
164. Palsamy, P., and Subramanian, S. (2011). Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim. Biophys. Acta 1812, 719-731. doi:10.1016/j.bbadis.2011.03.008
165. Peng, N., Clark, J. T., Prasain, J., Kim, H., White, C. R., and Wyss, J. M. (2005). Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol . 289, R771-R775. doi:10.1152/ajpregu.00147.2005
166. Penumathsa, S. V., Thirunavukkarasu, M., Zhan, L., Maulik, G., Menon, V. P., Bagchi, D., et al. (2008). Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J. Cell. Mol. Med . 12, 2350-2361. doi:10.1111/j.1582-4934.2008.00251.x
167. Perez-Vizcaino, F., Duarte, J., Jimenez, R., Santos-Buelga, C., and Osuna, A. (2009). Antihypertensive effects of the flavonoid quercetin. Pharmacol. Rep . 61, 67-75. doi:10.1016/S1734-1140(09)70008-8
168. Pervaiz, S., and Holme, A. L. (2009). Resveratrol: its biologic targets and functional activity. Antioxid. Redox Signal . 11, 2851-2897. doi:10.1089/ars.2008.2412
169. Pirola, L., and Frojdo, S. (2008). Resveratrol: one molecule, many targets. IUBMB Life 60, 323-332. doi:10.1002/iub.47
170. Pollack, R. M., and Crandall, J. P. (2013). Resveratrol: therapeutic potential for improving cardiometabolic health. Am. J. Hypertens . 26, 1260-1268. doi:10.1093/ajh/hpt165
171. Potente, M., and Dimmeler, S. (2008). Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7, 2117-2122. doi:10.4161/cc.7.14.6267
172. Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stodkilde-Jorgensen, H., et al. (2013). High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62, 1186-1195. doi:10.2337/db12-0975
173. Puddu, P., Puddu, G. M., Cravero, E., Rosati, M., and Muscari, A. (2008). The molecular sources of reactive oxygen species in hypertension. Blood Press . 17, 70-77. doi:10.1080/08037050802029954
174. Purushothaman, S., Renuka Nair, R., Harikrishnan, V. S., and Fernandez, A. C. (2011). Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat. Mol. Cell. Biochem . 351, 59-64. doi:10.1007/s11010-011-0711-y
175. Rabi, D. M., Daskalopoulou, S. S., Padwal, R. S., Khan, N. A., Grover, S. A., Hackam, D. G., et al. (2011). The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can. J. Cardiol . 27, 415-433.e1-2. doi:10.1016/j.cjca.2011.03.015
176. Raijmakers, M. T., Dechend, R., and Poston, L. (2004). Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 44, 374-380. doi:10.1161/01.HYP.0000141085.98320.01
177. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., et al. (1996). Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest . 97, 1916-1923.
178. Redon, J., Oliva, M. R., Tormos, C., Giner, V., Chaves, J., Iradi, A., et al. (2003). Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41, 1096-1101. doi:10.1161/01.HYP.0000068370.21009.38
179. Ren, Y., D'Ambrosio, M. A., Liu, R., Pagano, P. J., Garvin, J. L., and Carretero, O. A. (2010). Enhanced myogenic response in the afferent arteriole of spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol . 298, H1769-H1775. doi:10.1152/ajpheart.00537.2009
180. Renaud, S., and de Lorgeril, M. (1992). Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526. doi:10.1016/0140-6736(92)91277-F
181. Rettig, R., Stauss, H., Folberth, C., Ganten, D., Waldherr, B., and Unger, T. (1989). Hypertension transmitted by kidneys from stroke-prone spontaneously hypertensive rats. Am. J. Physiol . 257(2 Pt 2), F197-F203.
182. Rimbaud, S., Ruiz, M., Piquereau, J., Mateo, P., Fortin, D., Veksler, V., et al. (2011). Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS ONE 6:e26391. doi:10.1371/journal.pone.0026391
183. Rodrigo, R., Prat, H., Passalacqua, W., Araya, J., Guichard, C., and Bachler, J. P. (2007). Relationship between oxidative stress and essential hypertension. Hypertens. Res . 30, 1159-1167. doi:10.1291/hypres.30.1159
184. Roman, R. J., and Kaldunski, M. L. (1988). Renal cortical and papillary blood flow in spontaneously hypertensive rats. Hypertension 11(6 Pt 2), 657-663. doi:10.1161/01.HYP.11.6.657
185. Romanowski, A., Murray, J. R., and Huston, M. J. (1960). Effects of hydrogen peroxide on normal and hypertensive rats. Pharm. Acta Helv . 35, 354-357.
186. Roson, M. I., Della Penna, S. L., Cao, G., Gorzalczany, S., Pandolfo, M., Cerrudo, C., et al. (2011). High-sodium diet promotes a profibrogenic reaction in normal rat kidneys: effects of Tempol administration. J. Nephrol . 24, 119-127. doi:10.5301/JN.2010.5824
187. Rush, J. W., Quadrilatero, J., Levy, A. S., and Ford, R. J. (2007). Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp. Biol. Med. (Maywood) . 232, 814-822.
188. Rybalkin, S. D., Rybalkina, I. G., Feil, R., Hofmann, F., and Beavo, J. A. (2002). Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells. J. Biol. Chem . 277, 3310-3317. doi:10.1074/jbc.M106562200
189. San Jose, G., Fortuno, A., Beloqui, O., Diez, J., and Zalba, G. (2008). NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin. Sci . 114, 173-182. doi:10.1042/CS20070130
190. Sarr, M., Chataigneau, M., Martins, S., Schott, C., El Bedoui, J., Oak, M. H., et al. (2006). Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc. Res . 71, 794-802. doi:10.1016/j.cardiores.2006.05.022
191. Savoia, C., Burger, D., Nishigaki, N., Montezano, A., and Touyz, R. M. (2011). Angiotensin, I. I., and the vascular phenotype in hypertension. Expert Rev. Mol. Med . 13:e11. doi:10.1017/S1462399411001815
192. Schlaich, M. P., Hering, D., Sobotka, P. A., Krum, H., and Esler, M. D. (2012). Renal denervation in human hypertension: mechanisms, current findings, and future prospects. Curr. Hypertens. Rep . 14, 247-253. doi:10.1007/s11906-012-0264-9
193. Schnackenberg, C. G., Welch, W. J., and Wilcox, C. S. (1998). Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32, 59-64. doi:10.1161/01.HYP.32.1.59
194. Schnackenberg, C. G., and Wilcox, C. S. (1999). Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 33(1 Pt 2), 424-428. doi:10.1161/01.HYP.33.1.424
195. Schnackenberg, C. G., and Wilcox, C. S. (2001). The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int . 59, 1859-1864. doi:10.1046/j.1523-1755.2001.0590051859.x
196. Sedeek, M., Hebert, R. L., Kennedy, C. R., Burns, K. D., and Touyz, R. M. (2009). Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr. Opin. Nephrol. Hypertens . 18, 122-127. doi:10.1097/MNH.0b013e32832923c3
197. Semba, R. D., Ferrucci, L., Bartali, B., Urpi-Sarda, M., Zamora-Ros, R., Sun, K., et al. (2014). Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern. Med . 174, 1077-1084. doi:10.1001/jamainternmed.2014.1582
198. Siemann, E. H., and Creasy, L. L. (1992). Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic . 43, 49-52.
199. Simic, D. V., Mimic-Oka, J., Pljesa-Ercegovac, M., Savic-Radojevic, A., Opacic, M., Matic, D., et al. (2006). Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J. Hum. Hypertens . 20, 149-155. doi:10.1038/sj.jhh.1001945
200. Singh, M., Mensah, G. A., and Bakris, G. (2010). Pathogenesis and clinical physiology of hypertension. Cardiol. Clin . 28, 545-559. doi:10.1016/j.ccl.2010.07.001
201. Soleas, G. J., Diamandis, E. P., and Goldberg, D. M. (1997). Resveratrol: a molecule whose time has come? And gone? Clin. Biochem . 30, 91-113.
202. Son, Y., Lee, J. H., Chung, H. T., and Pae, H. O. (2013). Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxid. Med. Cell. Longev . 2013:639541. doi:10.1155/2013/639541
203. Spaak, J., Merlocco, A. C., Soleas, G. J., Tomlinson, G., Morris, B. L., Picton, P., et al. (2008). Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter. Am. J. Physiol. Heart Circ. Physiol . 294, H605-H612. doi:10.1152/ajpheart.01162.2007
204. Stiaccini, G., Mannari, C., Bertelli, A. A., and Giovannini, L. (2012). Resveratrol-poor red wines modulate SIRT1 in human renal cells. Plant Foods Hum. Nutr . 67, 289-293. doi:10.1007/s11130-012-0296-y
205. Subramanian, M., Balasubramanian, P., Garver, H., Northcott, C., Zhao, H., Haywood, J. R., et al. (2011). Chronic estradiol-17beta exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol. Am. J. Physiol. Regul. Integr. Comp. Physiol . 300, R1560-R1568. doi:10.1152/ajpregu.00020.2011
206. Sugamura, K., and Keaney, J. F. Jr. (2011). Reactive oxygen species in cardiovascular disease. Free Radic. Biol. Med . 51, 978-992. doi:10.1016/j.freeradbiomed.2011.05.004
207. Taylor, N. E., Glocka, P., Liang, M., and Cowley, A. W. Jr. (2006a). NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 47, 692-698. doi:10.1161/01.HYP.0000203161.02046.8d
208. Taylor, N. E., Maier, K. G., Roman, R. J., and Cowley, A. W. Jr. (2006b). NO synthase uncoupling in the kidney of Dahl S rats: role of dihydrobiopterin. Hypertension 48, 1066-1071. doi:10.1161/01.HYP.0000248751.11383.7c
209. Thandapilly, S. J., Wojciechowski, P., Behbahani, J., Louis, X. L., Yu, L., Juric, D., et al. (2010). Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am. J. Hypertens . 23, 192-196. doi:10.1038/ajh.2009.228
210. Thomas, S. R., Witting, P. K., and Drummond, G. R. (2008). Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal . 10, 1713-1765. doi:10.1089/ars.2008.2027
211. Timmers, S., Auwerx, J., and Schrauwen, P. (2012). The journey of resveratrol from yeast to human. Aging 4, 146-158.
212. Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., et al. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab . 14, 612-622. doi:10.1016/j.cmet.2011.10.002
213. Toklu, H. Z., Sehirli, O., Ersahin, M., Suleymanoglu, S., Yiginer, O., Emekli-Alturfan, E., et al. (2010). Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. J. Pharm. Pharmacol . 62, 1784-1793. doi:10.1111/j.2042-7158.2010.01197.x
214. Tome-Carneiro, J., Larrosa, M., Yanez-Gascon, M. J., Davalos, A., Gil-Zamorano, J., Gonzalvez, M., et al. (2013). One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol. Res . 72, 69-82. doi:10.1016/j.phrs.2013.03.011
215. Tousoulis, D., Kampoli, A. M., Tentolouris, C., Papageorgiou, N., and Stefanadis, C. (2012). The role of nitric oxide on endothelial function. Curr. Vasc. Pharmacol . 10, 4-18. doi:10.2174/157016112798829760
216. Touyz, R. M. (2005). Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid. Redox Signal . 7, 1302-1314. doi:10.1089/ars.2005.7.1302
217. Touyz, R. M., and Briones, A. M. (2011). Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens. Res . 34, 5-14. doi:10.1038/hr.2010.201
218. Touyz, R. M., and Schiffrin, E. L. (2001). Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J. Hypertens . 19, 1245-1254. doi:10.1097/00004872-200107000-00009
219. Traber, M. G., and Stevens, J. F. (2011). Vitamins, C., and E: beneficial effects from a mechanistic perspective. Free Radic. Biol. Med . 51, 1000-1013. doi:10.1016/j.freeradbiomed.2011.05.017
220. Ungvari, Z., Csiszar, A., Huang, A., Kaminski, P. M., Wolin, M. S., and Koller, A. (2003). High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 108, 1253-1258. doi:10.1161/01.CIR.0000079165.84309.4D
221. Ungvari, Z., Orosz, Z., Rivera, A., Labinskyy, N., Xiangmin, Z., Olson, S., et al. (2007). Resveratrol increases vascular oxidative stress resistance. Am. J. Physiol. Heart Circ. Physiol . 292, H2417-H2424. doi:10.1152/ajpheart.01258.2006
222. Vidavalur, R., Otani, H., Singal, P. K., and Maulik, N. (2006). Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp. Clin. Cardiol . 11, 217-225.
223. Vitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., et al. (2003). Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci . 72, 2219-2233. doi:10.1016/S0024-3205(03)00096-1
224. Walker, L. M., York, J. L., Imam, S. Z., Ali, S. F., Muldrew, K. L., and Mayeux, P. R. (2001). Oxidative stress and reactive nitrogen species generation during renal ischemia. Toxicol. Sci . 63, 143-148. doi:10.1093/toxsci/63.1.143
225. Wang, D., Strandgaard, S., Iversen, J., and Wilcox, C. S. (2009). Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol . 296, R195-R200. doi:10.1152/ajpregu.90506.2008
226. Wang, Z., Herzog, C., Kaushal, G. P., Gokden, N., and Mayeux, P. R. (2011). Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis. Shock 35, 141-147. doi:10.1097/SHK.0b013e3181ec39cc
227. Ward, N. C., Hodgson, J. M., Puddey, I. B., Mori, T. A., Beilin, L. J., and Croft, K. D. (2004). Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Free Radic. Biol. Med . 36, 226-232. doi:10.1016/j.freeradbiomed.2003.10.021
228. Weseler, A. R., and Bast, A. (2010). Oxidative stress and vascular function: implications for pharmacologic treatments. Curr. Hypertens. Rep . 12, 154-161. doi:10.1007/s11906-010-0103-9
229. Whaley-Connell, A., Habibi, J., Johnson, M., Tilmon, R., Rehmer, N., Rehmer, J., et al. (2009). Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat. Am. J. Nephrol . 30, 354-360. doi:10.1159/000229305
230. Widder, J. D., Fraccarollo, D., Galuppo, P., Hansen, J. M., Jones, D. P., Ertl, G., et al. (2009). Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension 54, 338-344. doi:10.1161/HYPERTENSIONAHA.108.127928
231. Wilcox, C. S. (2005). Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol . 289, R913-R935. doi:10.1152/ajpregu.00250.2005
232. Wilcox, C. S. (2012). Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension 59, 375-381. doi:10.1161/HYPERTENSIONAHA.111.187310
233. Wilkins, K., Campbell, N. R., Joffres, M. R., McAlister, F. A., Nichol, M., Quach, S., et al. (2010). Blood pressure in Canadian adults. Health Rep . 21, 37-46.
234. Wind, S., Beuerlein, K., Armitage, M. E., Taye, A., Kumar, A. H., Janowitz, D., et al. (2010). Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 56, 490-497. doi:10.1161/HYPERTENSIONAHA.109.149187
235. Wingler, K., Wunsch, S., Kreutz, R., Rothermund, L., Paul, M., and Schmidt, H. H. (2001). Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo . Free Radic. Biol. Med . 31, 1456-1464. doi:10.1016/S0891-5849(01)00727-4
236. Wong, R. H., Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., and Berry, N. M. (2011). Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr. Metab. Cardiovasc. Dis . 21, 851-856. doi:10.1016/j.numecd.2010.03.003
237. Xia, L., Wang, X. X., Hu, X. S., Guo, X. G., Shang, Y. P., Chen, H. J., et al. (2008). Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br. J. Pharmacol . 155, 387-394. doi:10.1038/bjp.2008.272
238. Ye, S., Zhong, H., Yanamadala, S., and Campese, V. M. (2006). Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 48, 309-315. doi:10.1161/01.HYP.0000231307.69761.2e
239. Yu, P., Han, W., Villar, V. A., Li, H., Arnaldo, F. B., Concepcion, G. P., et al. (2011). Dopamine D1 receptor-mediated inhibition of NADPH oxidase activity in human kidney cells occurs via protein kinase A-protein kinase C cross talk. Free Radic. Biol. Med . 50, 832-840. doi:10.1016/j.freeradbiomed.2010.12.027
240. Zinkevich, N. S., and Gutterman, D. D. (2011). ROS-induced ROS release in vascular biology: redox-redox signaling. Am. J. Physiol. Heart Circ. Physiol . 301, H647-H653. doi:10.1152/ajpheart.01271.2010
241. Zou, A. P., Li, N., and Cowley, A. W. Jr. (2001). Production and actions of superoxide in the renal medulla. Hypertension 37(2 Pt 2), 547-553. doi:10.1161/01.HYP.37.2.547
242. Zubcevic, J., Waki, H., Raizada, M. K., and Paton, J. F. (2011). Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension. Hypertension 57, 1026-1033. doi:10.1161/HYPERTENSIONAHA.111.169748